サマリー

世界の動物治療薬・診断薬市場は、2020年には334億6250万ドルとなり、2021年から2030年までのCAGRは5.9%を記録し、2030年には590億8210万ドルに達すると予測されます。動物治療学には、多くの疾患の治療に使用される可能性のある様々な治療項目が含まれます。動物のあらゆる病気の診断には、さまざまな検査や技術が利用されています。動物診断と動物治療の両方が、病気の治療には欠かせません。肉、タンパク質、牛乳などの生活必需品を動物に依存する人類が増えるにつれ、動物の健康の持続可能性はますます重要になる。病気はさまざまな診断テストや装置で診断され、治療薬はその作用機序に基づいて投与されます。診断テストや治療製品の多くは、動物病院で必要とされています。
畜産動物やペット動物における動物の健康に関する知識の増加や、コンパニオンアニマルの飼育率の上昇により、市場は予測期間を通じて緩やかに成長すると予想されます。また、肉類・牛乳の消費量の増加や人獣共通感染症の流行も、市場拡大に大きく寄与しています。しかし、診断・治療費用の高騰や動物への薬剤の過剰使用は、一般市民や動物の健康に深刻な影響を与え、市場の成長を阻害する可能性があります。さらに、ペットの飼い主が動物の福祉について理解していないことも、動物診断薬・治療薬産業の成長を阻害する要因となっています。
動物治療学と診断学の主要企業は、動物の行動や健康を監視するためのさまざまなテストキットや診断キットを発売しています。例えば、2021年10月、動物用医薬品およびワクチンのメーカーであるZoetis Inc.は、同社のVetscan Imagyst製品にデジタル細胞診検査を開始しました。Vetscan Imagystは、糞便検査のAI技術に加え、熟練した遠隔病理医のネットワークも提供するようになりました。さらに、2021年6月、Zoetis Inc.は、Restigen、PRP、Pro-Stride APS、CenTrateBMAを発表し、馬のオーセケア製品を拡大しました。これらのデバイスは、足を引きずる原因となる馬の怪我に対処するために設計されています。このような製品の導入は、市場の成長を促進する重要な要因となっています。
市場は、製品タイプ、動物タイプ産業、地域に区分されます。製品タイプにより、市場は動物診断薬製品と動物治療薬製品に分類されます。動物種別では、コンパニオンアニマル、牛、豚、鶏、羊に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（英国、フランス、ドイツ、イタリア、その他の欧州）、アジア太平洋（中国、日本、インド、韓国、その他のアジア太平洋）、LAMEA（中南米、中東、アフリカ）で世界市場の分析が行われます。

競合分析
世界の動物治療薬・診断薬で事業を展開している主要企業は、Zoetis Inc.、Elanco Animal Health Incorporated、Boehringer Ingelheim International GmbH、Virbac、Idexx Laboratories Inc、Ceva Sante Animale、Sanofi S.A、Heska Corporation、Thermo Fisher Scientific Inc、およびRandox Laboratories Ltd.である。

ページTOPに戻る

目次

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Animal Diagnostics Products
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Animal Therapeutics Products
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Companion Animals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Cattle
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Pigs
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Poultry
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Sheep
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
CHAPTER 6: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Product Type
6.2.3 North America Market size and forecast, by Animal Type
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Product Type
6.2.4.1.2 Market size and forecast, by Animal Type
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Product Type
6.2.4.2.2 Market size and forecast, by Animal Type
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Product Type
6.2.4.3.2 Market size and forecast, by Animal Type
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Product Type
6.3.3 Europe Market size and forecast, by Animal Type
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Product Type
6.3.4.1.2 Market size and forecast, by Animal Type
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Product Type
6.3.4.2.2 Market size and forecast, by Animal Type
6.3.4.3 U.K.
6.3.4.3.1 Market size and forecast, by Product Type
6.3.4.3.2 Market size and forecast, by Animal Type
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Product Type
6.3.4.4.2 Market size and forecast, by Animal Type
6.3.4.5 Rest of Europe
6.3.4.5.1 Market size and forecast, by Product Type
6.3.4.5.2 Market size and forecast, by Animal Type
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Product Type
6.4.3 Asia-Pacific Market size and forecast, by Animal Type
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Product Type
6.4.4.1.2 Market size and forecast, by Animal Type
6.4.4.2 India
6.4.4.2.1 Market size and forecast, by Product Type
6.4.4.2.2 Market size and forecast, by Animal Type
6.4.4.3 Japan
6.4.4.3.1 Market size and forecast, by Product Type
6.4.4.3.2 Market size and forecast, by Animal Type
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Product Type
6.4.4.4.2 Market size and forecast, by Animal Type
6.4.4.5 Rest of Asia-Pacific
6.4.4.5.1 Market size and forecast, by Product Type
6.4.4.5.2 Market size and forecast, by Animal Type
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Product Type
6.5.3 LAMEA Market size and forecast, by Animal Type
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Product Type
6.5.4.1.2 Market size and forecast, by Animal Type
6.5.4.2 Middle East
6.5.4.2.1 Market size and forecast, by Product Type
6.5.4.2.2 Market size and forecast, by Animal Type
6.5.4.3 Africa
6.5.4.3.1 Market size and forecast, by Product Type
6.5.4.3.2 Market size and forecast, by Animal Type
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Bayer AG
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Eli Lilly and Company
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Boehringer
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Ingelheim GmbH
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Merck and Co.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Zoetis Inc.
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Ceva Sante Animale
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Sanofi S.A.
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Nutreco N.V.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Virbac S.A.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments


LIST OF TABLES
TABLE 1. GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 2. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR ANIMAL DIAGNOSTICS PRODUCTS, BY REGION , 2020-2030,($MILLION)
TABLE 3. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET ANIMAL DIAGNOSTICS PRODUCTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR ANIMAL THERAPEUTICS PRODUCTS, BY REGION , 2020-2030,($MILLION)
TABLE 5. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET ANIMAL THERAPEUTICS PRODUCTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
TABLE 7. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR COMPANION ANIMALS, BY REGION , 2020-2030,($MILLION)
TABLE 8. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET COMPANION ANIMALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR CATTLE, BY REGION , 2020-2030,($MILLION)
TABLE 10. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET CATTLE BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR PIGS, BY REGION , 2020-2030,($MILLION)
TABLE 12. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET PIGS BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR POULTRY, BY REGION , 2020-2030,($MILLION)
TABLE 14. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET POULTRY BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR SHEEP, BY REGION , 2020-2030,($MILLION)
TABLE 16. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SHEEP BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 18. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 19. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
TABLE 20. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 21. U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 22. U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 23. CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 24. CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 25. MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 26. MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 27. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 28. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
TABLE 29. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 30. GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 31. GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 32. FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 33. FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 34. U.K. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 35. U.K. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 36. ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 37. ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 38. REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 39. REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 40. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 41. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
TABLE 42. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 43. CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 44. CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 45. INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 46. INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 47. JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 48. JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 49. SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 50. SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 51. REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 52. REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 53. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 54. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
TABLE 55. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 56. LATIN AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 57. LATIN AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 58. MIDDLE EAST ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 59. MIDDLE EAST ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 60. AFRICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 61. AFRICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
TABLE 62.BAYER AG: COMPANY SNAPSHOT
TABLE 63.BAYER AG: OPERATING SEGMENTS
TABLE 64.BAYER AG: PRODUCT PORTFOLIO
TABLE 65.BAYER AG: NET SALES,
TABLE 66.BAYER AG: KEY STRATERGIES
TABLE 67.ELI LILLY AND COMPANY: COMPANY SNAPSHOT
TABLE 68.ELI LILLY AND COMPANY: OPERATING SEGMENTS
TABLE 69.ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
TABLE 70.ELI LILLY AND COMPANY: NET SALES,
TABLE 71.ELI LILLY AND COMPANY: KEY STRATERGIES
TABLE 72.BOEHRINGER: COMPANY SNAPSHOT
TABLE 73.BOEHRINGER: OPERATING SEGMENTS
TABLE 74.BOEHRINGER: PRODUCT PORTFOLIO
TABLE 75.BOEHRINGER: NET SALES,
TABLE 76.BOEHRINGER: KEY STRATERGIES
TABLE 77.INGELHEIM GMBH: COMPANY SNAPSHOT
TABLE 78.INGELHEIM GMBH: OPERATING SEGMENTS
TABLE 79.INGELHEIM GMBH: PRODUCT PORTFOLIO
TABLE 80.INGELHEIM GMBH: NET SALES,
TABLE 81.INGELHEIM GMBH: KEY STRATERGIES
TABLE 82.MERCK AND CO.: COMPANY SNAPSHOT
TABLE 83.MERCK AND CO.: OPERATING SEGMENTS
TABLE 84.MERCK AND CO.: PRODUCT PORTFOLIO
TABLE 85.MERCK AND CO.: NET SALES,
TABLE 86.MERCK AND CO.: KEY STRATERGIES
TABLE 87.ZOETIS INC.: COMPANY SNAPSHOT
TABLE 88.ZOETIS INC.: OPERATING SEGMENTS
TABLE 89.ZOETIS INC.: PRODUCT PORTFOLIO
TABLE 90.ZOETIS INC.: NET SALES,
TABLE 91.ZOETIS INC.: KEY STRATERGIES
TABLE 92.CEVA SANTE ANIMALE: COMPANY SNAPSHOT
TABLE 93.CEVA SANTE ANIMALE: OPERATING SEGMENTS
TABLE 94.CEVA SANTE ANIMALE: PRODUCT PORTFOLIO
TABLE 95.CEVA SANTE ANIMALE: NET SALES,
TABLE 96.CEVA SANTE ANIMALE: KEY STRATERGIES
TABLE 97.SANOFI S.A.: COMPANY SNAPSHOT
TABLE 98.SANOFI S.A.: OPERATING SEGMENTS
TABLE 99.SANOFI S.A.: PRODUCT PORTFOLIO
TABLE 100.SANOFI S.A.: NET SALES,
TABLE 101.SANOFI S.A.: KEY STRATERGIES
TABLE 102.NUTRECO N.V.: COMPANY SNAPSHOT
TABLE 103.NUTRECO N.V.: OPERATING SEGMENTS
TABLE 104.NUTRECO N.V.: PRODUCT PORTFOLIO
TABLE 105.NUTRECO N.V.: NET SALES,
TABLE 106.NUTRECO N.V.: KEY STRATERGIES
TABLE 107.VIRBAC S.A.: COMPANY SNAPSHOT
TABLE 108.VIRBAC S.A.: OPERATING SEGMENTS
TABLE 109.VIRBAC S.A.: PRODUCT PORTFOLIO
TABLE 110.VIRBAC S.A.: NET SALES,
TABLE 111.VIRBAC S.A.: KEY STRATERGIES


LIST OF FIGURES
FIGURE 1.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SEGMENTATION
FIGURE 2.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030
FIGURE 3.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,BY PRODUCT TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ANIMAL DIAGNOSTICS PRODUCTS ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANIMAL THERAPEUTICS PRODUCTS ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
FIGURE 14.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,BY ANIMAL TYPE,2020(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF COMPANION ANIMALS ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CATTLE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PIGS ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF POULTRY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SHEEP ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
FIGURE 20.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY REGION,2020
FIGURE 21.U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 22.CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 23.MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 24.GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 25.FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 26.U.K. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 27.ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 28.REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 29.CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 30.INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 31.JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 32.SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 33.REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 34.LATIN AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 35.MIDDLE EAST ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 36.AFRICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
FIGURE 37. TOP WINNING STRATEGIES, BY YEAR
FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 40.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 41.COMPETITIVE DASHBOARD
FIGURE 42.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 43.BAYER AG.: NET SALES ,($MILLION)
FIGURE 44.ELI LILLY AND COMPANY.: NET SALES ,($MILLION)
FIGURE 45.BOEHRINGER.: NET SALES ,($MILLION)
FIGURE 46.INGELHEIM GMBH.: NET SALES ,($MILLION)
FIGURE 47.MERCK AND CO..: NET SALES ,($MILLION)
FIGURE 48.ZOETIS INC..: NET SALES ,($MILLION)
FIGURE 49.CEVA SANTE ANIMALE.: NET SALES ,($MILLION)
FIGURE 50.SANOFI S.A..: NET SALES ,($MILLION)
FIGURE 51.NUTRECO N.V..: NET SALES ,($MILLION)
FIGURE 52.VIRBAC S.A..: NET SALES ,($MILLION)